The Scientist - Home

A pill is shown on a blue technical background. One half of the pill has a DNA helix on it, and the other half has a depiction of a computer chip, representing the role of artificial intelligence in drug development.
| 3 min read
2026 will be the year that artificial intelligence accelerates multiple aspects of the drug discovery and development pipeline, industry leaders predict.

Latest

qPCRDriving Wastewater Surveillance for Infectious Disease

A clinician holding a graphic of the lungs on a tablet

Stem Cells Breathe New Life into Lungs

Kaitlyn Sadtler standing in front of a laboratory bench

Spectral Flow Cytometry: Separating the Fluorophore Rainbow

Fresh asparagus sliced horizontally, revealing inner microchannel structure.

Food for Thought: A Recipe for Regenerating Nerves

A graphic of the female reproductive system

Differentiated Stem Cells Can Kickstart Fertility in Mice

Accessible Lateral Flow Assays: Test to Treat, Test to Protect

Artistic rendering of a cancer cell in red with round, blue accents

Targeting Breast Cancer Metastasis

Mega Multiplexing for Exploring Diseased Tissues

Infant hands holding bottle of milk on light blue floor background.

Inositol in Human Breast Milk Improves Brain Connectivity

Artist’s impression of stem cells. The cells have a transparent cell membrane on a pale blue background.

Overcoming Cancer Therapy Obstacles With Epitope Editing

Close-up image of fat cells

A Snapshot of How Obesity Transforms Fat

Genetic engineering and digital technology concept.

A Machine Learning Tool Uncloaks the Hidden Sources of Cancer Cells

Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies